InMed Reports $1.0 Million Cash and Runway Into Mid-November

InMed reported $1.0 million in cash and cash equivalents at September 30, 2026, down from $2.2 million at June 30, 2026. The company expects available cash to fund planned expenses into mid-November. Nasdaq accepted its compliance plan, giving it until March 15, 2027, to regain compliance.